Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 23 Apr 2025

Tetramethylpyrazine alleviates acute pancreatitis inflammation by inhibiting pyroptosis via the NRF2 pathway

in Inflammation Pharmacology

Huangen Li
Yi Gao
Minglian Huang
Hongling Zhang
Qingqing Wu
Youpei Huang
Xiaotong Ye
Weiwen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557681

Original Research

Published on 23 Apr 2025

An off-target effect of class A CpG-oligonucleotides on suppressing the cyclic GMP-AMP synthase signaling in fibroblastic reticular cells

in Inflammation Pharmacology

Preethi Jayakumar
Ting Jiang
Hai Huang
Meihong Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576151

Original Research

Accepted on 22 Apr 2025

Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway

in Inflammation Pharmacology

Xin Zhou
Zhibin Wang
Yuting Wang
Guofeng Xu
Min Luo
Mengwei Zhang
Yuying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590096

Original Research

Accepted on 21 Apr 2025

Suppressing chondrocyte cuproptosis by syringaresinol-4-O-β-dglucoside alleviates gouty arthritis

in Inflammation Pharmacology

Shaotian Fu
Du Han
Xiao Ling
Hanyi Wang
Jianan Chen
Hang Zhang
Wugui Chen
Chengzhao Liu
Hailong Ma
成寿林

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565422

Review

Accepted on 18 Apr 2025

Curcumin: A potential anti-photoaging agent

in Inflammation Pharmacology

Yuhong Nie
Yiming Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559032

Original Research

Accepted on 16 Apr 2025

Effect of Methotrexate/Dexamethasone Combination on Epithelial-Mesenchymal Transition and Inflammation Gene Expression of Human RPE Cells In-Vitro

in Inflammation Pharmacology

Fatemeh Sanie-Jahromi
Mahdi Ravankhah
Shafi Khani
Ahmad Razavizadegan
M Hossein Nowroozzadeh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569703

Review

Published on 16 Apr 2025

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations

in Inflammation Pharmacology

Lingli Wang
Fengsong Nie
Zhaoyu Lu
Yang Chong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561112

303 views

Original Research

Accepted on 14 Apr 2025

Irisin restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis via regulating microglia activation

in Inflammation Pharmacology

Qiuxia Zhang
Lin-Jie Zhang
Ning Zhang
Li Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561939

Original Research

Accepted on 14 Apr 2025

Signal mining and analysis of sepsis-related adverse events in patients using immunosuppressive drugs based on the FDA Adverse Event Reporting System(FAERS)database

in Inflammation Pharmacology

XueHui Zhou
Hao Chen
Qiao-Lian Xu
Jia-Kui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598433

Original Research

Accepted on 11 Apr 2025

Anti-inflammatory effect and mechanism of stytontriterpene D on RAW264.7 cells and zebrafish

in Inflammation Pharmacology

Chuqin Yu
Gao Qiu
Quanwei Xie
Xiangying Liu
Zonghao Lin
Feng Wang
Lei Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559022

338 views

Original Research

Published on 09 Apr 2025

Umbilical cord stem cells therapy against bacterial pneumonia based on zebrafish pneumonia model

in Inflammation Pharmacology

Xueli Chen
Jian Jin
Xia Chen
Yabin Wu
Youjun Guo
Zuoyu Qian
Hui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546193

246 views

Review

Published on 09 Apr 2025

Oxidative stress in vascular surgical diseases: mechanisms, impacts and therapeutic perspectives

in Inflammation Pharmacology

Haosen Xu
Jin Yang
Zhanhui Wei
Shijie Bao
Zhuo Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527684

238 views

Review

Published on 08 Apr 2025

Anti-inflammatory drugs as potential antimicrobial agents: a review

in Inflammation Pharmacology

Onyedika Emmanuel Okpala
Johana Rondevaldova
Ladislav Kokoska

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557333

757 views

Original Research

Accepted on 07 Apr 2025

S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation

in Inflammation Pharmacology

Fiona Sailer
Megan Palmer
Blerina Aliraj
Jan Heering
Andreas Brockmann
Mohammed A F Elewa
Aissa Röhrig
Ewgenij Proschak
Dariusz T Stepniak
Simeon Ramsey

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590816

154 views

Review

Published on 07 Apr 2025

Paeoniflorin: a review of its pharmacology, pharmacokinetics and toxicity in diabetes

in Inflammation Pharmacology

Xue Ou
Zhijie Yu
Chuanyu Pan
Xi Zheng
Dandan Li
Zhenzhen Qiao
Xiaoyuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551368

443 views

Review

Published on 07 Apr 2025

Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway

in Inflammation Pharmacology

Jie Cui
Haonan Li
Tianyi Zhang
Fengli Lin
Meiyun Chen
Guimin Zhang
Zhong Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548073

347 views